News & Updates

Show Multimedia Only

Prophylactic 5-FU plus heparin not effective against proliferative vitreoretinopathy in RRD

14 Jun 2022

Adjuvant therapy with 5-fluorouracil (5-FU) and low molecular weight heparin in high-risk patients with rhegmatogenous retinal detachment (RRD) does not help prevent the development of proliferative vitreoretinopathy, as shown in a study.

14 Jun 2022

Treatment outcomes for nAMD, DMO, RVO poorer in clinical practice than in trials

13 Jun 2022

In clinical practice, patients with neovascular age-related macular degeneration (nAMD), diabetic macular oedema (DMO), and retinal vein occlusion (RVO) see treatment outcomes that are inferior to those reported in pivotal phase 3 studies, according to a recent study.

13 Jun 2022

Reticular pseudodrusen promotes progression to late AMD

09 Jun 2022

Individuals who present with reticular pseudodrusen (RPD) are at high risk of progression to late age-related macular degeneration (AMD), with the risk increase varying by RPD severity, as shown in a post hoc analysis of two clinical trials. The risk of progression is high at low-to-moderate RPD levels and low at high RPD levels.

09 Jun 2022

High-frequency mutations seen in conjunctival melanoma

06 Jun 2022

Patients with conjunctival melanoma exhibit a high frequency of BRAF and NRAS mutations, as well as ATRX and NF1 mutations, reports a study.

06 Jun 2022

Vision impairment linked to depression, anxiety among kids

06 Jun 2022

Children with vision impairment often experience greater symptoms of depression and anxiety, according to a recent study. Surgical treatment helps improve these mental health symptoms.

06 Jun 2022

Intravitreal ziv-aflibercept improves vision outcomes in diabetic macular oedema

06 Jun 2022

The use of intravitreal ziv-aflibercept (IVZ) in diabetic macular oedema (DME) improves best-corrected visual acuity (BCVA) and reduces central macular thickness (CMT), a recent study has found.

06 Jun 2022

Alcohol use ups risk of open-angle glaucoma

05 Jun 2022

Alcohol consumption appears to increase the likelihood of developing open-angle glaucoma (OAG), suggests a recent study.

05 Jun 2022

Rapid macular thinning an early sign of hydroxychloroquine retinopathy

28 May 2022

In patients on long-term hydroxychloroquine (HCQ) therapy, rapid macular thinning appears to alert a potential retinal damage related to HCQ treatment, a study has found.

28 May 2022